📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-08 17:03
145 analysed today
FollowTelegram
145
Today
149,546
All-time analysed
42,894
Positive
6,654
Negative
91,325
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
11 announcements match the current filters (relevance ≥ 5).
MD and CFO Ketanbhai Gosai Resigns; Satish Sahadev Kalmaste Appointed for 5 Years
Leading Leasing Finance and Investment Company announced that Mr. Ketanbhai Shivabhai Gosai resigned from his dual role as Managing Director and Chief Financial Officer effective 8th October 2026 due to other professional commitments. Concurrently, the Board has appointed Mr. Satish Sahadev Kalmaste as MD for a term of 5 years (until 7th October 2031) and CFO effective 8th October 2026. Mr. Kalmaste holds a B.Com degree with over 11 years of experience in accounts, finance, and income tax, and owns zero shares in the company. This management transition occurs amid volatile financial performance, following a Rs 20.36 Cr loss reported in Q1 FY27 (June 2026).
Confidence: HIGH
What changedKetanbhai Shivabhai Gosai resigned as both MD and CFO, and Satish Sahadev Kalmaste was appointed to take over both roles effective 8th October 2026.
Why it mattersA simultaneous change in both top executive roles (MD and CFO) introduces governance and strategic transition risks for a micro-cap NBFC currently navigating quarterly net losses.
MD Appointment Tenure: 5 years (8th October 2026 to 7th October 2031)Incoming MD & CFO Shareholding: NILIncoming MD Experience: over 11 yearsLatest Quarterly Net Loss (Jun 2026): Rs -20.36 Cr
📅 Short termMarket sentiment may remain cautious as key executive transitions take effect while the business addresses profitability challenges.
📈 Long termStrategic execution and risk controls under the new leadership will determine whether the company can recover from recent operational losses and expand its leasing portfolio sustainably.
⚠ Risk flags
- Dual concentration of MD and CFO roles in a single individual
- Recent operational volatility marked by a Rs 20.36 Cr net loss in Jun 2026
Key Highlights
Ketanbhai Shivabhai Gosai resigned as MD and CFO effective close of business hours on 8th October 2026.
Satish Sahadev Kalmaste appointed as MD for a 5-year term from 8th October 2026 to 7th October 2031, subject to shareholder approval.
Satish Sahadev Kalmaste concurrently appointed as Chief Financial Officer (CFO) effective 8th October 2026.
Incoming MD & CFO holds 0 shares in the company and brings over 11 years of experience in Accounts, Finance, and Income Tax.
Board meeting approving the appointments commenced at 03:30 PM and concluded at 04:00 PM on 8th October 2026.
👀 What to Watch
Track the upcoming general meeting for shareholder approval of the new Managing Director's appointment and watch subsequent quarterly results to see if the leadership change stabilizes earnings after recent operational losses.
MD and CFO Ketanbhai Gosai Resigns; Satish Sahadev Kalmaste Appointed for 5 Years
Leading Leasing Finance and Investment Company announced that Mr. Ketanbhai Shivabhai Gosai resigned from his dual role as Managing Director and Chief Financial Officer effective 8th October 2026 due to other professional commitments. Concurrently, the Board has appointed Mr. Satish Sahadev Kalmaste as MD for a term of 5 years (until 7th October 2031) and CFO effective 8th October 2026. Mr. Kalmaste holds a B.Com degree with over 11 years of experience in accounts, finance, and income tax, and owns zero shares in the company. This management transition occurs amid volatile financial performance, following a Rs 20.36 Cr loss reported in Q1 FY27 (June 2026).
Confidence: HIGH
What changedKetanbhai Shivabhai Gosai resigned as both MD and CFO, and Satish Sahadev Kalmaste was appointed to take over both roles effective 8th October 2026.
Why it mattersA simultaneous change in both top executive roles (MD and CFO) introduces governance and strategic transition risks for a micro-cap NBFC currently navigating quarterly net losses.
MD Appointment Tenure: 5 years (8th October 2026 to 7th October 2031)Incoming MD & CFO Shareholding: NILIncoming MD Experience: over 11 yearsLatest Quarterly Net Loss (Jun 2026): Rs -20.36 Cr
📅 Short termMarket sentiment may remain cautious as key executive transitions take effect while the business addresses profitability challenges.
📈 Long termStrategic execution and risk controls under the new leadership will determine whether the company can recover from recent operational losses and expand its leasing portfolio sustainably.
⚠ Risk flags
- Dual concentration of MD and CFO roles in a single individual
- Recent operational volatility marked by a Rs 20.36 Cr net loss in Jun 2026
Key Highlights
Ketanbhai Shivabhai Gosai resigned as MD and CFO effective close of business hours on 8th October 2026.
Satish Sahadev Kalmaste appointed as MD for a 5-year term from 8th October 2026 to 7th October 2031, subject to shareholder approval.
Satish Sahadev Kalmaste concurrently appointed as Chief Financial Officer (CFO) effective 8th October 2026.
Incoming MD & CFO holds 0 shares in the company and brings over 11 years of experience in Accounts, Finance, and Income Tax.
Board meeting approving the appointments commenced at 03:30 PM and concluded at 04:00 PM on 8th October 2026.
👀 What to Watch
Track the upcoming general meeting for shareholder approval of the new Managing Director's appointment and watch subsequent quarterly results to see if the leadership change stabilizes earnings after recent operational losses.
MD and CFO Ketanbhai Gosai Resigns; Satish Sahadev Kalmaste Appointed for 5 Years
Leading Leasing Finance and Investment Company announced that Mr. Ketanbhai Shivabhai Gosai resigned from his dual role as Managing Director and Chief Financial Officer effective 8th October 2026 due to other professional commitments. Concurrently, the Board has appointed Mr. Satish Sahadev Kalmaste as MD for a term of 5 years (until 7th October 2031) and CFO effective 8th October 2026. Mr. Kalmaste holds a B.Com degree with over 11 years of experience in accounts, finance, and income tax, and owns zero shares in the company. This management transition occurs amid volatile financial performance, following a Rs 20.36 Cr loss reported in Q1 FY27 (June 2026).
Confidence: HIGH
What changedKetanbhai Shivabhai Gosai resigned as both MD and CFO, and Satish Sahadev Kalmaste was appointed to take over both roles effective 8th October 2026.
Why it mattersA simultaneous change in both top executive roles (MD and CFO) introduces governance and strategic transition risks for a micro-cap NBFC currently navigating quarterly net losses.
MD Appointment Tenure: 5 years (8th October 2026 to 7th October 2031)Incoming MD & CFO Shareholding: NILIncoming MD Experience: over 11 yearsLatest Quarterly Net Loss (Jun 2026): Rs -20.36 Cr
📅 Short termMarket sentiment may remain cautious as key executive transitions take effect while the business addresses profitability challenges.
📈 Long termStrategic execution and risk controls under the new leadership will determine whether the company can recover from recent operational losses and expand its leasing portfolio sustainably.
⚠ Risk flags
- Dual concentration of MD and CFO roles in a single individual
- Recent operational volatility marked by a Rs 20.36 Cr net loss in Jun 2026
Key Highlights
Ketanbhai Shivabhai Gosai resigned as MD and CFO effective close of business hours on 8th October 2026.
Satish Sahadev Kalmaste appointed as MD for a 5-year term from 8th October 2026 to 7th October 2031, subject to shareholder approval.
Satish Sahadev Kalmaste concurrently appointed as Chief Financial Officer (CFO) effective 8th October 2026.
Incoming MD & CFO holds 0 shares in the company and brings over 11 years of experience in Accounts, Finance, and Income Tax.
Board meeting approving the appointments commenced at 03:30 PM and concluded at 04:00 PM on 8th October 2026.
👀 What to Watch
Track the upcoming general meeting for shareholder approval of the new Managing Director's appointment and watch subsequent quarterly results to see if the leadership change stabilizes earnings after recent operational losses.
MD and CFO Ketanbhai Gosai Resigns; Satish Sahadev Kalmaste Appointed for 5 Years
Leading Leasing Finance and Investment Company announced that Mr. Ketanbhai Shivabhai Gosai resigned from his dual role as Managing Director and Chief Financial Officer effective 8th October 2026 due to other professional commitments. Concurrently, the Board has appointed Mr. Satish Sahadev Kalmaste as MD for a term of 5 years (until 7th October 2031) and CFO effective 8th October 2026. Mr. Kalmaste holds a B.Com degree with over 11 years of experience in accounts, finance, and income tax, and owns zero shares in the company. This management transition occurs amid volatile financial performance, following a Rs 20.36 Cr loss reported in Q1 FY27 (June 2026).
Confidence: HIGH
What changedKetanbhai Shivabhai Gosai resigned as both MD and CFO, and Satish Sahadev Kalmaste was appointed to take over both roles effective 8th October 2026.
Why it mattersA simultaneous change in both top executive roles (MD and CFO) introduces governance and strategic transition risks for a micro-cap NBFC currently navigating quarterly net losses.
MD Appointment Tenure: 5 years (8th October 2026 to 7th October 2031)Incoming MD & CFO Shareholding: NILIncoming MD Experience: over 11 yearsLatest Quarterly Net Loss (Jun 2026): Rs -20.36 Cr
📅 Short termMarket sentiment may remain cautious as key executive transitions take effect while the business addresses profitability challenges.
📈 Long termStrategic execution and risk controls under the new leadership will determine whether the company can recover from recent operational losses and expand its leasing portfolio sustainably.
⚠ Risk flags
- Dual concentration of MD and CFO roles in a single individual
- Recent operational volatility marked by a Rs 20.36 Cr net loss in Jun 2026
Key Highlights
Ketanbhai Shivabhai Gosai resigned as MD and CFO effective close of business hours on 8th October 2026.
Satish Sahadev Kalmaste appointed as MD for a 5-year term from 8th October 2026 to 7th October 2031, subject to shareholder approval.
Satish Sahadev Kalmaste concurrently appointed as Chief Financial Officer (CFO) effective 8th October 2026.
Incoming MD & CFO holds 0 shares in the company and brings over 11 years of experience in Accounts, Finance, and Income Tax.
Board meeting approving the appointments commenced at 03:30 PM and concluded at 04:00 PM on 8th October 2026.
👀 What to Watch
Track the upcoming general meeting for shareholder approval of the new Managing Director's appointment and watch subsequent quarterly results to see if the leadership change stabilizes earnings after recent operational losses.
Withdraws Approval For 35.71 Cr Equity Shares And 70.94 Cr Convertible Warrants
Leading Leasing Finance and Investment Company has decided to withdraw its in-principle approval applications submitted to BSE and MSE. The withdrawn applications were for the allotment of 35,71,42,856 equity shares pursuant to conversion of existing debt/loans and 70,93,57,119 convertible warrants. This planned transaction would have represented a massive equity issuance (over 106.6 crore total potential shares) compared to the company's current market cap of Rs 67 Cr. Consequently, the proposed debt conversion and warrant capital infusion will not proceed in their current form.
Confidence: HIGH
What changedThe company has cancelled its planned issuance of 35.71 crore equity shares (for loan conversion) and 70.94 crore convertible warrants by withdrawing stock exchange applications.
Why it mattersThe company remains encumbered by existing debt that was slated for conversion into equity, leaving balance-sheet liabilities unresolved while eliminating potential future cash inflows from warrants.
Equity shares for loan conversion withdrawn: 35,71,42,856Convertible warrants withdrawn: 70,93,57,119Meeting conclusion date: October 5, 2026
📅 Short termLikely negative sentiment as investors react to the cancellation of proposed debt reduction and capital-raising initiatives.
📈 Long termOngoing debt servicing could pressure profitability (TTM PAT already negative at Rs -7 Cr), unless management proposes an alternative capitalization structure.
⚠ Risk flags
- Unresolved existing debt obligations following the cancellation of loan-to-equity conversion
- No reason specified for the sudden withdrawal of exchange applications
Key Highlights
Withdrew in-principle application for allotment of 35,71,42,856 equity shares via loan conversion
Withdrew in-principle application for 70,93,57,119 convertible warrants
Total potential shares/warrants withdrawn stand at 1,06,64,99,975 units
Board meeting commenced at 04:30 PM and concluded at 05:00 PM on October 5, 2026
👀 What to Watch
Watch for management commentary regarding alternative debt-settlement mechanisms or revised fundraising plans, as well as upcoming Q2 FY27 earnings for debt and balance-sheet impact.
LLFICL plans AGM vote to issue up to 35.71 Cr shares and 70.94 Cr warrants on preferential basis
Leading Leasing Finance and Investment Company Ltd has issued its FY26 Annual Report and AGM notice scheduled for September 26, 2026. Key special resolutions include increasing the authorised share capital from Rs 60.00 Cr to Rs 164.00 Cr. The company also seeks shareholder approval to issue up to 35,71,42,856 equity shares to non-promoters upon conversion of outstanding unsecured loans, alongside 70,93,57,119 convertible warrants on a preferential basis.
Confidence: HIGH
What changedThe company has formally tabled shareholder resolutions to hike authorized capital by 173% and issue over 106.6 Cr combined shares and warrants via preferential allotment.
Why it mattersConverting unsecured loans into equity and issuing sizeable convertible warrants will alter the capital structure, eliminate debt overheads, but cause significant dilution for existing shareholders relative to the current Rs 57 Cr market cap.
Authorised Capital Hike: Rs 60.00 Cr to Rs 164.00 CrPreferential Shares (Loan Conversion): 35,71,42,856 sharesPreferential Convertible Warrants: 70,93,57,119 warrantsAGM Date: 26th September 2026
📅 Short termMarket reaction may reflect anticipation around shareholder voting outcomes and the pricing terms of the preferential issuance.
📈 Long termIf successfully converted, the new equity infusion could strengthen net worth and reduce leverage, though substantial equity expansion may dilute per-share earnings unless deployment delivers commensurate profit growth.
⚠ Risk flags
- Severe shareholding dilution risk from massive share and warrant issuance
- Shareholder and regulatory approval risks for preferential allotment
- Volatile profitability (FY26 revenue Rs 147.1 Cr, Q1 FY27 loss Rs 20.36 Cr)
Key Highlights
Proposed increase in authorised share capital from Rs 60.00 Cr to Rs 164.00 Cr (164 Cr equity shares of Rs 1 each)
Issuance of up to 35,71,42,856 equity shares on preferential basis upon conversion of outstanding unsecured loans
Issuance of up to 70,93,57,119 convertible warrants on a preferential basis to non-promoter category
42nd Annual General Meeting scheduled for Saturday, September 26, 2026 at 11:30 AM IST
👀 What to Watch
Track the AGM voting results on September 26, 2026, and subsequent allotment details to monitor potential massive equity dilution and reduction in debt liabilities.
Leading Leasing to Convert ₹50 Cr Unsecured Debt into Equity; Seeks AGM Nod for Capital Hike
Leading Leasing Finance has issued a notice for its 42nd AGM on September 26, 2026, seeking shareholder approval for major capital structure changes. The company plans to increase its authorized share capital from ₹60 crore to ₹164 crore. Additionally, it proposed issuing up to 35.71 crore equity shares at ₹1.40 each (aggregating ₹50 crore) to two non-promoter entities via conversion of unsecured loans, along with the issuance of 70.94 crore convertible warrants.
Confidence: HIGH
What changedThe company called its 42nd AGM to approve a ₹50 crore debt-to-equity conversion, an issue of ~70.94 crore convertible warrants, and an increase in authorized capital from ₹60 crore to ₹164 crore.
Why it mattersThe ₹50 crore loan conversion represents ~88% of the company's current market cap (₹57 crore), extinguishing substantial debt but resulting in massive equity dilution for existing shareholders.
Debt Conversion Value: ₹50.00 croreDebt Conversion vs Market Cap: ~87.7%Shares to be Issued (Debt Swap): 35,71,42,856Issue Price per Share: ₹1.40Convertible Warrants: 70,93,57,119Authorized Capital Increase: ₹60.00 crore to ₹164.00 crore
📅 Short termShareholders will focus on the voting outcome at the September 26, 2026 AGM regarding the substantial dilution and capital restructuring.
📈 Long termWhile converting ₹50 crore of debt to equity strengthens net worth and relieves cash outflow obligations, the massive expansion of the share base will significantly dilute future EPS.
⚠ Risk flags
- Substantial equity dilution from 35.71 crore new shares and 70.94 crore potential warrant conversions
- High concentration of newly issued equity among two non-promoter entities
Key Highlights
Conversion of ₹50.00 crore unsecured loans into 35,71,42,856 equity shares at ₹1.40 per share (FV ₹1 + ₹0.40 premium)
Proposed increase in authorized share capital from ₹60.00 crore to ₹164.00 crore
Issuance of 70,93,57,119 convertible warrants on a preferential basis to non-promoters
AGM scheduled for September 26, 2026, to vote on debt conversion, warrant issue, and MD re-appointment
👀 What to Watch
Track shareholder voting results from the September 26, 2026 AGM, along with regulatory and stock exchange in-principle approval timelines for the large equity and warrant issuance.
LLFICL Approves Rs 149.3 Cr Preferential Issue of 106.6 Cr Equity Shares & Warrants at Rs 1.40
Leading Leasing Finance and Investment Company Ltd has approved a major capital restructuring and fundraise. The board approved increasing the authorized share capital from Rs 60 Cr to Rs 164 Cr. It approved issuing 35.71 Cr equity shares at Rs 1.40 per share (worth ~Rs 50 Cr) via conversion of unsecured loans to 2 non-promoter lenders, alongside 70.94 Cr convertible warrants at Rs 1.40 per warrant (worth ~Rs 99.3 Cr) to 51 non-promoter investors. The combined total issue of Rs 149.3 Cr significantly exceeds the company's current market cap of Rs 57 Cr.
Confidence: HIGH
What changedThe board approved a combined preferential issue of 106.65 Cr shares/warrants worth ~Rs 149.3 Cr to convert unsecured loans and raise fresh equity.
Why it mattersThe massive issuance (representing nearly 2.6x the current market cap) will clean up unsecured debt by Rs ~50 Cr while potentially bringing in Rs ~99.3 Cr in cash, but it results in extreme equity dilution.
Authorized Capital Increase: Rs 164,00,00,000Equity Shares Issued on Loan Conversion: 35,71,42,856Convertible Warrants Issued: 70,93,57,119Issue Price per Share/Warrant: Rs. 1.40Total Fundraise/Conversion vs Market Cap: ~262%
📅 Short termShareholders will vote on the resolutions ahead of the AGM; stock may experience volatility given the scale of dilution relative to existing share capital.
📈 Long termIf successfully converted and warrants are exercised, the debt burden eases and capital base expands, but massive share dilution will substantially lower EPS on any recovery.
⚠ Risk flags
- Severe equity dilution from issuance of 106.65 Cr shares and warrants
- Pending shareholder and stock exchange regulatory approvals
Key Highlights
Increase in authorized share capital from Rs 60 Cr to Rs 164 Cr (164 Cr shares of Re 1 each).
Issuance of up to 35.71 Cr equity shares at Rs 1.40 each (~Rs 50 Cr) via conversion of unsecured loans to 2 non-promoter allottees.
Issuance of up to 70.94 Cr convertible warrants at Rs 1.40 each (~Rs 99.31 Cr) on a preferential basis to 51 non-promoter allottees.
Warrants are convertible into equity shares within 18 months from allotment.
All proposals are subject to shareholder approval at the 42nd AGM with remote e-voting from Sept 23 to Sept 25, 2026.
👀 What to Watch
Track the upcoming shareholder voting at the 42nd AGM, stock exchange listing approvals, and the timeline of warrant subscription and equity dilution.
Leading Leasing Finance Approves Q1 FY27 (Quarter Ended June 30, 2026) Financial Results
Leading Leasing Finance and Investment Company Limited approved its unaudited financial results along with the Limited Review Report for the quarter ended June 30, 2026, at its board meeting on August 22, 2026. The meeting commenced at 5:15 PM and concluded at 6:00 PM. Detailed P&L line items were not included in the primary transmittal text. Investors should review full statement disclosures to evaluate revenue and margin trajectory following a TTM revenue base of Rs 147 Cr.
Confidence: LOW
What changedFormal approval and submission of unaudited financial statements for the quarter ended June 30, 2026.
Why it mattersProvides updated quarterly operational performance and balance sheet health for the micro-cap NBFC.
Quarter ended: June 30, 2026Meeting duration: 05:15 PM to 06:00 PMTTM Revenue (Context): Rs 147 CrTTM PAT (Context): Rs 19 Cr
📅 Short termMarket reaction will depend on detailed profitability metrics once full statements are digested.
📈 Long termLimited, as periodic quarterly earnings are standard compliance events.
⚠ Risk flags
- Historical earnings volatility (swinging from Rs 18.35 Cr profit in Dec 2025 to Rs -7.08 Cr loss in Mar 2026)
- Micro-cap illiquidity
Key Highlights
Board approved Unaudited Financial Results for the quarter ended June 30, 2026
Board meeting held on August 22, 2026, from 05:15 PM to 06:00 PM
Limited Review Report received from Statutory Auditors of the company
Detailed financial numbers not disclosed in the transmittal extract
👀 What to Watch
Track the full financial tables on the exchange disclosures to assess quarterly revenue and profitability trends against the prior quarter net loss of Rs 7.08 Cr in March 2026.
Leading Leasing Finance Board Approves Q1 Results For Quarter Ended June 30, 2026
Leading Leasing Finance and Investment Company Limited announced that its Board of Directors approved the unaudited financial results and Limited Review Report for the quarter ended June 30, 2026. The board meeting was held on August 22, 2026, from 05:15 PM to 06:00 PM. While the formal approval was communicated under SEBI LODR Regulations 30 and 33, detailed line-item financial metrics were omitted in the cover disclosure extract.
Confidence: MEDIUM
What changedFormal approval and adoption of the company's Q1 financial results for the quarter ended June 30, 2026.
Why it mattersProvides statutory updates on financial performance and asset-backed financing operations of the NBFC.
Quarter ended: June 30, 2026Meeting date: August 22, 2026Meeting duration: 05:15 PM to 06:00 PM
📅 Short termMarket focus will be on assessing full quarterly P&L numbers and credit cost trends once detailed tables are examined.
📈 Long termLimited; structural growth relies on expanding industrial leasing and hire purchase books amid competitive spread pressures.
⚠ Risk flags
- Financial figures omitted from the cover text extract
- Earnings volatility observed in prior quarters
Key Highlights
Board approved unaudited financial results for the quarter ended June 30, 2026
Statutory auditors issued a Limited Review Report for the quarterly results
Board meeting commenced at 05:15 PM and concluded at 06:00 PM on August 22, 2026
👀 What to Watch
Track the detailed standalone financial statements to evaluate revenue growth and margin recovery following the loss of Rs 7.08 Cr reported in the March 2026 quarter.
45 Crore Share Preferential Issue and Debt Conversion Withdrawn by Leading Leasing Finance
Leading Leasing Finance and Investment Company Ltd has decided to withdraw its applications for the issuance of 45 crore equity shares. This includes 40 crore shares that were to be issued to non-promoters upon the conversion of outstanding unsecured loans and an additional 5 crore shares on a preferential basis. The applications for in-principle approval were previously submitted to BSE and MSE. This decision effectively halts the planned debt-to-equity conversion and the associated equity dilution.
Confidence: HIGH
What changedThe company has cancelled its previous plan to issue 45 crore new equity shares, which would have converted debt into equity and raised additional capital.
Why it mattersThe withdrawal prevents significant equity dilution for existing shareholders but leaves the unsecured debt on the company's balance sheet, which may impact future interest obligations and liquidity.
Shares for loan conversion: 40,00,00,000Preferential issue shares: 5,00,00,000Total shares withdrawn: 45,00,00,000Board meeting date: July 16, 2026
📅 Short termThe stock may face pressure as the market digests the cancellation of the fundraise and the continued presence of unsecured debt.
📈 Long termThe company's ability to manage its debt without equity conversion will be a key structural factor to watch over the coming quarters.
⚠ Risk flags
- Unsecured debt remains on balance sheet
- Potential regulatory or procedural hurdles leading to withdrawal
- Uncertainty regarding future capital raising plans
Key Highlights
Withdrawal of application for 40,00,00,000 equity shares intended for unsecured loan conversion
Withdrawal of application for 5,00,00,000 equity shares on a preferential basis
Total of 45,00,00,000 shares affected by the board's decision to cancel the issuance
Board meeting concluded within 40 minutes (02:00 P.M. to 02:40 P.M.) on July 16, 2026
👀 What to Watch
Investors should monitor the company's next steps regarding the settlement of its outstanding unsecured loans, as the planned conversion into equity has been cancelled.
